Payden & Rygel Investment Group Zoetis Inc. Transaction History
Payden & Rygel Investment Group
- $2.12 Billion
- Q1 2024
A detailed history of Payden & Rygel Investment Group transactions in Zoetis Inc. stock. As of the latest transaction made, Payden & Rygel Investment Group holds 70,990 shares of ZTS stock, worth $12.5 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
70,990
Previous 103,590
31.47%
Holding current value
$12.5 Million
Previous $18 Million
33.35%
% of portfolio
0.57%
Previous 1.23%
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
1,859Shares Held
416MCall Options Held
1.13MPut Options Held
1.81M-
Vanguard Group Inc Valley Forge, PA40.7MShares$7.16 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.7MShares$6.45 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$3.44 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.84 Billion2.46% of portfolio
-
Bank Of America Corp Charlotte, NC14MShares$2.45 Billion0.22% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.2B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...